These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3863996)

  • 21. Ofloxacin II.
    Infection; 1986; 14 Suppl 4():S221-S338. PubMed ID: 3469150
    [No Abstract]   [Full Text] [Related]  

  • 22. [Incidence of atypical mycobacteria in an epidemiological tuberculosis sample survey in 6 provinces and 2 municipalities].
    Xu MY
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):214-5. PubMed ID: 7172930
    [No Abstract]   [Full Text] [Related]  

  • 23. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
    Chierakul N; Klomsawat D; Chulavatnatol S; Chindavijak B
    Int J Tuberc Lung Dis; 2001 Mar; 5(3):278-82. PubMed ID: 11326828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
    Ye Z; Pei X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.
    Tsukamura M; Nakamura E; Yoshii S; Amano H
    Am Rev Respir Dis; 1985 Mar; 131(3):352-6. PubMed ID: 3856412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR; Diacon AH
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A preliminary study on the definition of resistant breakpoints of ofloxacin and levofloxacin for Mycobacterium tuberculosis].
    Huang XR; Gao WW; Zhang XX; Wang SM; Pan YX; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):84-8. PubMed ID: 14990180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of urinary infections after kidney transplant with ofloxacin (RG 191). Preliminary results].
    Prati GF; Recchia G; Dean P; Galvani E; Muolo A; Fostini R; Ancona G
    G Ital Chemioter; 1985; 32(2):501-4. PubMed ID: 3914437
    [No Abstract]   [Full Text] [Related]  

  • 29. Pulmonary infections by atypical mycobacteria in a rural coastal region of Karnataka, India.
    Kotian M; Ganesan V; Sarvamangala JN; Shivananda PG; Achyutha KN
    Trop Geogr Med; 1981 Jun; 33(2):117-21. PubMed ID: 7281210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Differential diagnosis of tuberculosis--(b). Excretion of atypical mycobacterium].
    Shimode H
    Kekkaku; 1982 Oct; 57(10):548-52. PubMed ID: 6819379
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical study of tuberactinomycin-N in pulmonary tuberculosis (author's transl)].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1973 Oct; 48(10):473-9. PubMed ID: 4780239
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and microbiological efficacy of adjunctive salvage therapy with inhaled aminoglycosides in a patient with refractory cavitary pulmonary tuberculosis.
    Parola P; Brouqui P
    Clin Infect Dis; 2001 Oct; 33(8):1439. PubMed ID: 11565088
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on lung disease due to atypical mycobacteria in Japan--Report of the study in 1979 (author's transl)].
    Kekkaku; 1981 Aug; 56(8):391-401. PubMed ID: 7339146
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on lung disease due to non-tuberculous mycobacteria in Japan (report of the year 1983 of the Mycobacteriosis Research Group of the Japanese National Chest Hospitals)].
    Tsukamura M; Kita N; Shimoide H; Nagasawa S; Arakawa H; Kuze A; Shinoda A; Takasawa N; Kamimura H; Wada R
    Kekkaku; 1985 May; 60(5):299-308. PubMed ID: 4032948
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
    Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary mycobacteriosis. Clinical and bacteriological aspects].
    Llamos Durive RA; Suárez Méndez RF; Barbón Ruiz D
    Rev Cubana Med Trop; 1982; 34(3):308-14. PubMed ID: 6820978
    [No Abstract]   [Full Text] [Related]  

  • 37. [Two cases of pulmonary disease caused by Mycobacterium chelonae subsp. abscessus].
    Naoki K; Oosumi M; Takasugi T; Toyoda T; Kawashiro T; Aoyagi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Nov; 34(11):1264-70. PubMed ID: 8976085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Resistance pattern of Mycobacterium tuberculosis strain H37Rv to a new antibiotic DL 8280].
    Tsukamura M
    Kekkaku; 1984 May; 59(5):337-9. PubMed ID: 6434783
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on lung diseases due to non-tuberculous mycobacteria in Japan. (Report of the year 1982 of the Mycobacteriosis Research Group of the Japanese National Chest Hospitals). Isolation of various species that caused lung diseases].
    Tsukamura M; Kita N; Shimoide H; Nagasawa S; Kawakami K; Ito T; Mitani Y; Otsuka W; Yoshimoto K; Wada T
    Kekkaku; 1984 May; 59(5):329-36. PubMed ID: 6482144
    [No Abstract]   [Full Text] [Related]  

  • 40. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.